September 22, 2021 Employee Perspective: Celebrating Diversity of Thought and Action We have all had to come together, trusting each other to come up with solutions that celebrate diversity of thought and action. Read More ›
September 6, 2021 Co-Creating with Patients, for Patients: Addressing Unmet Needs in Conversations about AT ... Collaborating with patient organizations and patients is an essential part of our efforts to support people living with a complex rare disease like hereditary A Read More ›
September 4, 2021 Guest Post: Tracking My hATTR Amyloidosis Symptoms to Take Back Control David, from the UK, is living with hereditary ATTR amyloidosis. In this article, he discusses how he's using the STAR Symptom Tracker App to track his symptoms Read More ›
August 4, 2021 Culture of Innovation Brings Recognition as a Best Workplace for Innovators by Fast Compan ... Long recognized for its culture of innovation, Alnylam has been named a Best Workplace for Innovators for 2021 by Fast Company, ranking #11 out of 100 Read More ›
May 28, 2021 Putting People First Has Never Been More Important Kasha Witkos, SVP Head of CEMEA Region at Alnylam discusses Alnylam's offices in UK, Switzerland and Germany being named Best Workplaces by Great Place to Work Read More ›
April 26, 2021 Diversity Equity & Inclusion at Alnylam: Building on the Momentum to Create Lasting Impact ... Sara Nochur, Alnylam's Chief Diversity, Equity & Inclusion Officer talks about DE&I at Alnylam and her role leading the company's efforts. Read More ›
April 15, 2021 Guest Post: Partnering to Make a Positive Difference for People with Kidney Disease LaVarne Burton, President and CEO of the American Kidney Fund talks about the importance of partnerships Read More ›
March 12, 2021 Decades of Pain and Uncertainty: Donna’s AHP Story For more than 20 years, Donna navigated debilitating pain, mysterious symptoms and uncertainty about her health. Today, with a better handle on her wellbeing Read More ›
March 11, 2021 Alnylam Publishes First Corporate Responsibility Summary Today, we've published Alnylam's first Corporate Responsibility Summary detailing our approach to corporate responsibility and the actions we are and intend to Read More ›
March 2, 2021 When Are Kidney Stones a Red Flag? According to some estimates, every 1 in 10 adults in the U.S. experiences a kidney stone, suggesting that kidney stones can be rather prevalent. But when are st Read More ›

Get In Touch

Have any questions or comments about the content you see on this page?

You are now leaving

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site